about
LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activationResilience to bacterial infection: difference between species could be due to proteins in serumComparative Study of Injury Models for Studying Muscle Regeneration in MiceLow titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.Centenary of the death of Elie Metchnikoff: a visionary and an outstanding team leader.DNAemia detection by multiplex PCR and biomarkers for infection in systemic inflammatory response syndrome patients.Simple method for repurification of endotoxins for biological useIn vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosisDifferential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammationDoes the shape of lipid A determine the interaction of LPS with Toll-like receptors?TLR9 activation is triggered by the excess of stimulatory versus inhibitory motifs present in Trypanosomatidae DNA.A Transcriptomic Biomarker to Quantify Systemic Inflammation in Sepsis - A Prospective Multicenter Phase II Diagnostic StudyThe historical milestones in the understanding of leukocyte biology initiated by Elie Metchnikoff.Structural and functional analyses of bacterial lipopolysaccharides.Endotoxin tolerance: is there a clinical relevance?Corticosteroids in sepsis: from bench to bedside?Altered immune status of circulating T lymphocytes during sepsis: children also.Cytokine cascade in sepsis.Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeabilityMechanisms of immunodysregulation in sepsis.Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women.Infection-Mediated Priming of Phagocytes Protects against Lethal Secondary Aspergillus fumigatus ChallengeThe WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory responseMonocytes/macrophages and sepsis.Compartmentalization of the inflammatory response in sepsis and SIRS.Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsisStress molecules in sepsis and systemic inflammatory response syndrome.Determining the degree of immunodysregulation in sepsis.Early events in innate immunity in the recognition of microbial pathogens.Good and bad fever.Toll-like receptors expression and interferon-γ production by NK cells in human sepsisExpression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages.Translocation of bacterial NOD2 agonist and its link with inflammation.Natural killer (NK) cells in antibacterial innate immunity: angels or devils?Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty?Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology?TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals.Host response biomarkers in the diagnosis of sepsis: a general overview.Recent developments in severe sepsis research: from bench to bedside and back.
P50
Q24312754-669986A5-F230-4D15-A963-4BC1EF9341ABQ24654161-D1F88031-39BB-4FD1-A9B8-4ED31A69A7DEQ27329538-1E99584A-436C-40C8-B841-33C4BA9EA68AQ30360402-DDC753ED-6CA1-4D17-98BD-55011AE784E6Q30389193-9E8DEECB-4464-4CD7-A53C-6484BDB60450Q31068457-26533D07-A7B0-42C1-89C9-726FC90AB5B7Q33270792-537D05FE-4C6C-4382-8F61-63EB2B04F0C1Q33551044-40316B7E-CB28-4B70-8BD0-1216E65B9DF2Q33919242-08DD8834-AB63-4C49-80F1-939DC498F484Q34115875-2AE63196-7FBE-4C98-BF28-DE64355667CFQ34505652-C26DF62E-E860-4EAF-BD05-9D519E77E6A1Q34527815-9876BB3D-E57B-4CE3-AAC5-E060754286F6Q34629676-D1299607-E6D7-4D27-B521-44786115F3E4Q34727370-B081C678-F49D-4EAF-949C-FF28C66AC5B8Q35153199-20C4A3A9-16DC-493A-8889-DFD8E495CCB9Q35201445-7D96E4C4-80D6-4D23-BA4C-C6D097DFC559Q35580678-DC23AEC0-BA1A-416E-9574-1ABF118B68F6Q35585026-5683AE91-7AA4-4391-8A35-B2B85F26B73FQ35781403-799F844A-4541-4166-BB71-B93471AF04B6Q35841196-D36C7501-AF7D-4612-B04A-7C9DF1828BDAQ35853618-5AD31F28-F738-43C2-953D-CB8F7134138DQ35990087-9A0B85DA-F515-4732-A505-B2F9196C5C45Q36277416-395C075C-0257-4300-BE5A-E53C514BD17CQ36337625-B4EA60FA-4758-4A1E-9E0E-476C57D0E8DFQ36486397-7A8F2AA9-C241-499D-9470-D2BE08B07631Q36625054-4DAA9534-496E-441E-8AC4-4435F4249A1AQ36788696-54324225-2058-4FC3-8420-9145863F6CFAQ36803542-2F08D42B-3C16-47CB-AC38-4BA9C0F36F09Q36842742-8B982F0B-74CA-430F-A537-2A765691015BQ36925754-AA3EB291-BF01-45DC-AD4C-D6D898C288DEQ36928269-4B642E1F-6B11-4756-A880-34D9FA53E010Q37296391-5F148824-83CC-4F70-8A4A-140B1172520BQ37304848-F5A26DA9-EB92-4E3F-80C1-91AAF3AC07ECQ37360336-D052B3EB-D71E-4D9C-B1D1-6EC6A00C0963Q37959322-2C37B597-9745-4329-9721-BDA3BEFAED56Q38133638-22B063C5-E521-4678-9CAE-60B1A55479CDQ38133641-B89C524F-4506-4C66-B33A-B0783E70B04EQ38173691-558BE01E-13DA-4D4F-93C0-034C4920F807Q38260623-1AB07DBF-0466-433E-B586-4E831A8F53FAQ38724278-05599132-1D29-4090-BE8F-681786E3A1BA
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jean-Marc Cavaillon
@ast
Jean-Marc Cavaillon
@en
Jean-Marc Cavaillon
@es
Jean-Marc Cavaillon
@fr
Jean-Marc Cavaillon
@nl
Jean-Marc Cavaillon
@sl
type
label
Jean-Marc Cavaillon
@ast
Jean-Marc Cavaillon
@en
Jean-Marc Cavaillon
@es
Jean-Marc Cavaillon
@fr
Jean-Marc Cavaillon
@nl
Jean-Marc Cavaillon
@sl
prefLabel
Jean-Marc Cavaillon
@ast
Jean-Marc Cavaillon
@en
Jean-Marc Cavaillon
@es
Jean-Marc Cavaillon
@fr
Jean-Marc Cavaillon
@nl
Jean-Marc Cavaillon
@sl
P1006
P1015
P214
P244
P268
P269
P1006
P1015
P106
P1960
W7kqpAEAAAAJ
P2038
Jean-Marc_Cavaillon
P21
P213
0000 0000 5557 5013
P214
P244
nb2008024403
P268
P269
P2798
P31
P496
0000-0001-7721-2106
P569
1950-01-01T00:00:00Z
P735
P7859
lccn-nb2008024403